These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6295973)

  • 21. Miconazole therapy for keratomycosis.
    Foster CS
    Am J Ophthalmol; 1981 May; 91(5):622-9. PubMed ID: 6263095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ketoconazole. 3 years' experience with a new orally active broadspectrum antimycotic].
    Haneke E
    Z Hautkr; 1982 Aug; 57(16):1165-76. PubMed ID: 6291267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Severe Aspergillus keratomycosis treated with itraconazole per os].
    Villard C; Lacroix C; Rabot MH; Rovira JC; Jacquemin JL
    J Fr Ophtalmol; 1989; 12(4):323-5. PubMed ID: 2560784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatic, clinical and histologic evaluation of corneal tissues in experimental fungal keratitis in rabbits.
    Gopinathan U; Ramakrishna T; Willcox M; Rao CM; Balasubramanian D; Kulkarni A; Vemuganti GK; Rao GN
    Exp Eye Res; 2001 Apr; 72(4):433-42. PubMed ID: 11273671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of Aspergillus keratitis in vivo with confocal microscopy.
    Winchester K; Mathers WD; Sutphin JE
    Cornea; 1997 Jan; 16(1):27-31. PubMed ID: 8985630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The clinical and pathogenic characteristics of keratitis caused by Alternaria alternata].
    Sun ST; Wang LY; Xu J; Wei QC; Li JX
    Zhonghua Yan Ke Za Zhi; 2007 Jan; 43(1):32-5. PubMed ID: 17442160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Condition responsive nanoparticles for managing infection and inflammation in keratitis.
    Ahsan SM; Rao CM
    Nanoscale; 2017 Jul; 9(28):9946-9959. PubMed ID: 28681884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
    Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
    Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspergillus flavus keratitis after laser in situ keratomileusis.
    Sridhar MS; Garg P; Bansal AK; Gopinathan U
    Am J Ophthalmol; 2000 Jun; 129(6):802-4. PubMed ID: 10926994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of voriconazole against corneal isolates of Scedosporium apiospermum.
    Shah KB; Wu TG; Wilhelmus KR; Jones DB
    Cornea; 2003 Jan; 22(1):33-6. PubMed ID: 12502945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans-induced keratomycosis.
    Gyanfosu L; Koffuor GA; Kyei S; Ababio-Danso B; Peprah-Donkor K; Nyansah WB; Asare F
    Int Ophthalmol; 2018 Oct; 38(5):2089-2100. PubMed ID: 28900810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keratitis due to Aspergillus flavus successfully treated with thiabendazole.
    Upadhyay MP; West EP; Sharma AP
    Br J Ophthalmol; 1980 Jan; 64(1):30-2. PubMed ID: 6766732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
    Troke PF; Andrews RJ; Marriott MS; Richardson K
    J Antimicrob Chemother; 1987 May; 19(5):663-70. PubMed ID: 3038824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspergillus flavus Keratitis: Experience of a Tertiary Eye Clinic in Turkey.
    Erdem E; Yagmur M; Boral H; Ilkit M; Ersoz R; Seyedmousavi S
    Mycopathologia; 2017 Apr; 182(3-4):379-385. PubMed ID: 27826683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycolase II: an enzyme antifungal agent interacts with the polyene antibiotic pimaricin in the treatment of keratomycosis.
    Oji EO
    Int Ophthalmol; 1982 Nov; 5(3):175-9. PubMed ID: 6984030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
    Schmitt HJ; Edwards F; Andrade J; Niki Y; Armstrong D
    Chemotherapy; 1992; 38(2):118-26. PubMed ID: 1317280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.
    Shobana CS; Mythili A; Homa M; Galgóczy L; Priya R; Babu Singh YR; Panneerselvam K; Vágvölgyi C; Kredics L; Narendran V; Manikandan P
    J Mycol Med; 2015 Mar; 25(1):44-9. PubMed ID: 25541256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
    Zhang J; Wang L; Gao C; Zhang L; Xia H
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Keratomycosis after cataract surgery.
    Mendicute J; Orbegozo J; Ruiz M; Sáiz A; Eder F; Aramberri J
    J Cataract Refract Surg; 2000 Nov; 26(11):1660-6. PubMed ID: 11084276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug.
    Sayed S; Elsayed I; Ismail MM
    Int J Pharm; 2018 Oct; 549(1-2):249-260. PubMed ID: 30077759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.